Healthcare & Life Sciences
TScan Therapeutics
United Statestscan.biz
TScan Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 5 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2015
Founded
5
Investors
About TScan Therapeutics
TScan Therapeutics is a company founded in 2015 headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 5 investors associated with the company.
TScan Therapeutics develops anti-tumor T cell receptors (TCRs) by identifying their antigens through a genome-wide high-throughput platform, enabling new immuno-oncology treatments for patients not served by current cancer therapies.
Explore TScan Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.